GREY:DGCRF - Post by User
Post by
Fantomatuson Sep 16, 2009 5:40pm
200 Views
Post# 16312318
Much ado about...something
Much ado about...somethingOne thing is sure in my mind, as in J.Shafer's mind too (I assume) : Cur can't be run two more years
with its normal burn rate that implies huge efforts in R&D without finding liquidities.
And because the stock market is not favourable ( and I think it will getting worst in the coming months),
he will have no choice to find a big partner in order to sell the GCC test with efficiency.
That's why he is right to wait the second part results of Dr. Waldman's study and to complete
the work on the SHC test. And this should happen in 2010. Two major ways to predict and
prognosticate colorectal cancer.
Thus , he will get the best position to negociate a partnership.
Fantomatus